Answers are grounded in this paper and cite their sources.
Retrospective analysis demonstrates survival outcomes in patients with colorectal liver metastases treated with microwave ablation, suggesting its effectiveness.
Background Colorectal cancer (CRC) is the third most common cancer worldwide, with 25-30% of patients develop liver metastases (CRLM). Although hepatic resection remains the preferred treatment, recurrence occurs in 50-70% of cases. Thermal ablation is increasingly used for unresectable and deep seeded metastases < 3cm. Stereotactic microwave ablation (SMWA) has emerged as a highly precise ablation technique offering planning, navigation and validation during the intervention and the possibility to treat invisible lesions by MRI fusion. Aims A comprehensive analysis of patients undergoing SMWA for CRLM aims to identify factors influencing recurrence, oncological outcome and overall survival. Methods Retrospective analysis of a cohort of 89 patients treated at the Bern University Hospital for CRLM with SMWA between 2014 and 2024 Results A total of 89 patients underwent SMWA, with a mean age of 65.5 years. A total of 56 (62.9%) patients presented with synchronous CRLM at the time of SMWA. A total of 172 lesions in 105 interventions were treated. Post-interventional complications occurred in 5 (5.6%) patients. The overall survival, from the first treatment to last Follow-up was 35.6 (±22) months, disease progression was seen in 65 (73%) patients, whereas local recurrence after SMWA was observed in 30 (17.4%) patients, with a mean recurrence-free survival of 7.8 (±5.2) months. Fifteen (50%) of patients with local recurrence were treated with subsequent surgical resection. The influence of the ablation margin using an ablation validation software and a potential correlation with tumor size and anatomic location will now be assessed in order to identify risk factors for recurrence. Conclusion In this cohort, post-interventional complications were infrequent, and both overall survival and local recurrence rates were consistent with those reported in the literature following ablation or resection. SMWA for CRLM represents a safe and effective local treatment option.
No takes yet. Share an insight, caveat, or question.
Fiore et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: